Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - QUESTCOR PHARMACEUTICALS INC | d324129d10q.htm |
| EXCEL - IDEA: XBRL DOCUMENT - QUESTCOR PHARMACEUTICALS INC | Financial_Report.xls |
| EX-32.1 - SECTION 906 CEO CERTIFICATION - QUESTCOR PHARMACEUTICALS INC | d324129dex321.htm |
| EX-31.2 - SECTION 302 CFO CERTIFICATION - QUESTCOR PHARMACEUTICALS INC | d324129dex312.htm |
| EX-31.1 - SECTION 302 CEO CERTIFICATION - QUESTCOR PHARMACEUTICALS INC | d324129dex311.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Questcor Pharmaceuticals, Inc. (the “Company”) for the period ended March 31, 2012 (the “Report”), I Michael H. Mulroy, Senior Vice President, Chief Financial Officer, General Counsel and Corporate Secretary of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: April 26, 2012
| /s/ MICHAEL H. MULROY |
| Michael H. Mulroy, Senior Vice President, Chief Financial Officer, General Counsel and Corporate Secretary (Principal Financial and Accounting Officer) |